Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

CVS Health : Lagging Pharmacies Court the Chronically Ill -- -2-

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/06/2019 | 02:48am EDT

Both companies say they will comply with health-privacy laws and won't share data with the retail side of the business.

CVS says its existing capital budgets will cover costs of reinventing stores nationwide. A Walgreens spokesman said investments would be made "in a financially disciplined manner," declining to further quantify.

Unlike CVS, which stopped selling tobacco products in 2014, Walgreens has continued to sell cigarettes in most of its stores, drawing criticism from federal regulators, lawmakers as well as activists who say that tobacco products don't belong in a health store. Mr. Pessina says the chain is testing some tobacco-free stores and is encouraging employees in others to offer aids to quit smoking to customers buying cigarettes.

One recent weekday afternoon, Mr. Pessina, the company's CEO, walked through a store near the company's Deerfield, Ill., headquarters. In an area called the "health corner" were signs for optical, lab, hearing and pharmacy services. As Mr. Pessina quizzed the in-store optometrist about the number of visitors he was getting, a customer shuffled by pushing a shopping cart with a case of Bud Light. Across the store, a woman had her blood pressure checked.

Mr. Pessina said he's convinced moving away from traditional retail is the only way forward. "We are also a retailer," he said. "But we are above all a pharmacy."

Write to Aisha Al-Muslim at aisha.al-muslim@wsj.com and Sharon Terlep at sharon.terlep@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 1.84% 61.39 Delayed Quote.-8.00%
WALGREENS BOOTS ALLIANCE 1.35% 51.16 Delayed Quote.-25.13%
This article is part of a news chaine.
Article 2 / 2
<< Preceding Next >>
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
08/19CVS HEALTH : Current report filing
PU
08/19CVS HEALTH CORP : Other Events (form 8-K)
AQ
08/19CVS HEALTH CORPORATION : Announces Final Results of Any and All Tender Offers an..
PR
08/16CVS SHAREHOLDER ALERT BY FORMER LOUI : Kahn Swick & Foti, LLC Reminds Investors ..
BU
08/15ROBBINS GELLER RUDMAN & DOWD LLP : Files Class Action Suit Against CVS Health Co..
BU
08/15CVS HEALTH : Entities Severed from October Bellwether Trial
PU
08/15CVS HEALTH CORPORATION : Announces Expiration and Results of Any and All Tender ..
PR
08/15AETNA : Better Health of Florida wins Florida Health Kids contract
PR
08/14CVS HEALTH CORP : Other Events (form 8-K)
AQ
08/14CVS HEALTH CORPORATION : Announces Pricing of Any and All Tender Offers
PR
More news
Financials (USD)
Sales 2019 253 B
EBIT 2019 15 026 M
Net income 2019 6 593 M
Debt 2019 62 460 M
Yield 2019 3,24%
P/E ratio 2019 12,1x
P/E ratio 2020 10,7x
EV / Sales2019 0,56x
EV / Sales2020 0,53x
Capitalization 79 837 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 70,20  $
Last Close Price 61,39  $
Spread / Highest target 49,9%
Spread / Average Target 14,4%
Spread / Lowest Target -5,52%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President